EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,529 | -13.8% | 8,914 | -9.1% | 0.04% | -12.5% |
| Q2 2023 | $80,695 | +13.9% | 9,805 | +0.4% | 0.05% | +23.1% |
| Q1 2023 | $70,825 | -40.9% | 9,769 | -27.7% | 0.04% | -38.1% |
| Q4 2022 | $119,922 | -6.3% | 13,520 | +29.5% | 0.06% | +23.5% |
| Q3 2022 | $128,000 | +4.1% | 10,440 | +0.7% | 0.05% | +10.9% |
| Q2 2022 | $123,000 | +19.4% | 10,370 | +91.2% | 0.05% | 0.0% |
| Q1 2022 | $103,000 | -32.2% | 5,425 | -5.5% | 0.05% | -19.3% |
| Q4 2021 | $152,000 | -33.0% | 5,740 | +4.0% | 0.06% | -43.0% |
| Q3 2021 | $227,000 | -31.0% | 5,518 | -5.0% | 0.10% | -25.9% |
| Q2 2021 | $329,000 | +60.5% | 5,806 | +18.9% | 0.14% | +55.2% |
| Q1 2021 | $205,000 | -39.0% | 4,884 | +1.8% | 0.09% | -37.4% |
| Q4 2020 | $336,000 | +5.0% | 4,798 | -58.0% | 0.14% | -17.3% |
| Q3 2020 | $320,000 | -16.7% | 11,417 | -12.1% | 0.17% | -7.7% |
| Q2 2020 | $384,000 | – | 12,987 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |